Anuradha Supun Dassanayake
Overview
Explore the profile of Anuradha Supun Dassanayake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mettananda C, Solangaarachchige M, Haddela P, Dassanayake A, Kasturiratne A, Wickremasinghe R, et al.
BMJ Open
. 2025 Jan;
15(1):e081434.
PMID: 39819943
Introduction: Models derived from non-Sri Lankan cohorts are used for cardiovascular (CV) risk stratification of Sri Lankans. Objective: To develop a CV risk prediction model using machine learning (ML) based...
2.
Mettananda C, Egodage T, Dantanarayana C, Fernando R, Ranaweera L, Luke N, et al.
BMJ Open
. 2023 Jan;
13(1):e063959.
PMID: 36639212
Introduction: Identification of advanced hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD) is important as this may progress to cirrhosis and hepatocellular carcinoma. The risk of hepatic fibrosis is especially...
3.
Khandelwal R, Dassanayake A, Singh S
Euroasian J Hepatogastroenterol
. 2022 Dec;
12(Suppl 1):S37-S40.
PMID: 36466100
How To Cite This Article: Khandelwal R, Dassanayake AS, Singh SP. Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist. Euroasian J Hepato-Gastroenterol 2022;12(Suppl 1):S37-S40.
4.
Singh S, Anirvan P, Reddy K, Conjeevaram H, Marchesini G, Rinella M, et al.
J Hepatol
. 2020 Dec;
74(4):972-974.
PMID: 33340575
No abstract available.
5.
Kasturiratne A, Ediriweera D, De Silva S, Niriella M, Thulani U, Pathmeswaran A, et al.
BMJ Open
. 2020 Sep;
10(9):e038772.
PMID: 32994253
Objective: To describe patterns and predictors of mortality in a semi-urban population in Sri Lanka. Design: A prospective population-based cohort study. Setting: Ragama Medical Officer of Health area in the...
6.
Niriella M, Kobbegala V, Karalliyadda H, Ranawaka C, De Silva A, Dassanayake A, et al.
BMC Res Notes
. 2017 Jul;
10(1):303.
PMID: 28732527
Background: As acute viral hepatitis can be fatal in patients with cirrhosis, vaccination against hepatitis A (HAV) and hepatitis B (HBV) is recommended for non-immune patients. With increasing affluence the...
7.
Niriella M, Kumarasena R, Dassanayake A, Pathirana A, De Silva Hewavisenthi J, de Silva H
J Med Case Rep
. 2016 Dec;
10(1):371.
PMID: 28003028
Background: Cefuroxime very rarely causes drug-induced liver injury. We present a case of a patient with paradoxical worsening of jaundice caused by cefuroxime-induced cholestasis following therapeutic endoscopic retrograde cholangiopancreatography for...
8.
Siriwardana R, Niriella M, Dassanayake A, Liyanage C, Gunetilleke B, de Silva H
Indian J Gastroenterol
. 2016 May;
35(3):222-4.
PMID: 27142096
Non-alcoholic fatty liver disease (NAFLD) seems to recur in at least one third of patients transplanted for non-alcoholic steatohepatitis (NASH)-related cirrhosis. While, NASH recurrence does not seem to affect overall...
9.
Siriwardana R, Niriella M, Dassanayake A, Liyanage C, Upasena A, Sirigampala C, et al.
BMC Gastroenterol
. 2015 Aug;
15:96.
PMID: 26239844
Background: Transarterial-chemo-embolization (TACE) is used for palliation of unresectable hepatocellular carcinoma (HCC). We studied the tolerability of TACE in a cohort of patients with NASH and alcoholic cirrhosis related HCC....
10.
Wijewantha H, De Silva A, Niriella M, Wijesinghe N, Waraketiya P, Kumarasena R, et al.
Gastroenterol Res Pract
. 2014 Feb;
2014:343849.
PMID: 24550980
Introduction. Available evidence for routine terminal ileoscopy during colonoscopy is equivocal. We investigated the place of routine terminal ileoscopy and biopsy during colonoscopy, in a tropical setting. Materials and Methods....